1.           Introduction

1.1          Scope of the Study

1.2          The Insight Partners Research Report Guidance

1.3          Market Segmentation

1.3.1          Asia Pacific Neurological Biomarker Market – By Product

1.3.2          Asia Pacific Neurological Biomarker Market – By Application

1.3.3          Asia Pacific Neurological Biomarker Market – By End User

1.3.4          Asia Pacific Neurological Biomarker Market – By Country

2.           Neurological Biomarker Market – Key Takeaways

3.           Research Methodology

3.1          Coverage

3.2          Secondary Research

3.3          Primary Research

4.           Neurological Biomarker Market – Market Landscape

4.1          Overview

4.2          PEST Analysis

4.2.1          Asia Pacific– PEST Analysis

4.3          Expert Opinion

5.           Neurological Biomarker Market – Key Market Dynamics

5.1          Key Market Drivers

5.1.1          Rising Prevalence of Neurological Diseases

5.1.2          Growing Focus on Neurological Biomarker Research

5.2          Key Market Restraints

5.2.1          Concerns Associated with Biomarkers

5.3          Key Market Opportunities

5.3.1          Increasing Awareness of Neurological Diseases Coupled with Developing Healthcare Infrastructure

5.4          Future Trends

5.4.1          The Rising Trend of Precision/Personalized Healthcare

5.5          Impact analysis

6.           Neurological Biomarker Market – Asia Pacific Analysis

6.1          Asia Pacific Neurological Biomarker Market Revenue Forecast and Analysis

7.           Neurological Biomarker Market Analysis– by Product

7.1          Overview

7.2          Neurological Biomarker Market Share, By Product, 2019 & 2027 (%)

7.3          Proteomics Biomarker

7.3.1          Overview

7.3.2          Proteomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

7.4          Genomics Biomarker

7.4.1          Overview

7.4.2          Genomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

7.5          Metabolomics Biomarker

7.5.1          Overview

7.5.2          Metabolomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

7.6          Imaging Biomarker

7.6.1          Overview

7.6.2          Imaging Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

7.7          Others

7.7.1          Overview

7.7.2          Others Market Revenue and Forecasts to 2027 (US$ Mn)

8.           Neurological Biomarker Market Analysis– by Application

8.1          Overview

8.2          Neurological Biomarker Market Share, By Application, 2019 & 2027 (%)

8.3          Alzheimer’s Disease

8.3.1          Overview

8.3.2          Alzheimer’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)

8.4          Parkinson’s Disease

8.4.1          Overview

8.4.2          Parkinson’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)

8.5          Schizophrenia

8.5.1          Overview

8.5.2          Schizophrenia Market Revenue and Forecasts to 2027 (US$ Mn)

8.6          Huntington's Disease

8.6.1          Overview

8.6.2          Huntington's Disease Market Revenue and Forecasts to 2027 (US$ Mn)

8.7          Spinal Muscular Atrophy

8.7.1          Overview

8.7.2          Spinal Muscular Atrophy Market Revenue and Forecasts to 2027 (US$ Mn)

8.8          Others

8.8.1          Overview

8.8.2          Others Market Revenue and Forecasts to 2027 (US$ Mn)

9.           Neurological Biomarker Market Analysis– by End User

9.1          Overview

9.2          Neurological Biomarker Market Share, By End User, 2019 & 2027 (%)

9.3          Pharmaceutical and Biotechnology Companies

9.3.1          Overview

9.3.2          Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)

9.4          Clinical Diagnostics

9.4.1          Overview

9.4.2          Clinical Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

9.5          Research Organizations

9.5.1          Overview

9.5.2          Research Organizations Market Revenue and Forecasts to 2027 (US$ Mn)

10.        Neurological Biomarker Market Analysis and Forecasts To 2027 – Asia Pacific Analysis

10.1        Asia Pacific: Neurological Biomarker Market

10.1.1        Overview

10.1.2        Asia Pacific: Neurological Biomarker Market - Revenue and Forecast to 2027 (USD Million)

10.1.3        Asia Pacific: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.1.4        Asia Pacific: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.1.5        Asia Pacific: Neurological Biomarker Market, by End-User, 2018–2027 (USD Million)

10.1.6        Asia Pacific: Neurological Biomarker Market, by Country, 2019& 2027 (%)

10.1.7        China: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1          China: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2          China: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.1.7.3          China: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.1.7.4          China: Neurological Biomarker Market, by End-User, 2018–2027 (USD Million)

10.1.8        Japan: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1          Japan: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2          Japan: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.1.8.3          Japan: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.1.8.4          Japan: Neurological Biomarker Market, by End-User, 2018–2027 (USD Million)

10.1.9        India: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1          India: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2          India: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.1.9.3          India: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.1.9.4          India: Neurological Biomarker Market, by End User, 2018–2027 (USD Million)

10.1.10      South Korea: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.10.1        South Korea: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.10.2        South Korea: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.1.10.3        South Korea: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.1.10.4        South Korea: Neurological Biomarker Market, by End User, 2018–2027 (USD Million)

10.1.11      Australia: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.11.1        Australia: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

10.1.11.2        Australia: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)

10.1.11.3        Australia: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)

10.1.11.4        Australia: Neurological Biomarker Market, by End User, 2018–2027 (USD Million)

11.        Impact of COVID-19 Pandemic on Asia Pacific Neurological Biomarker Market

11.1        Asia-Pacific: Impact Assessment of COVID-19 Pandemic

12.        Company Profiles

12.1        Thermo Fisher Scientific Inc.

12.1.1        Key Facts

12.1.2        Business Description

12.1.3        Products and Services

12.1.4        Financial Overview

12.1.5        SWOT Analysis

12.1.6        Key Developments

12.2        Abbott

12.2.1        Key Facts

12.2.2        Business Description

12.2.3        Products and Services

12.2.4        Financial Overview

12.2.5        SWOT Analysis

12.2.6        Key Developments

12.3        Bio-Rad Laboratories Inc.

12.3.1        Key Facts

12.3.2        Business Description

12.3.3        Products and Services

12.3.4        Financial Overview

12.3.5        SWOT Analysis

12.3.6        Key Developments

12.4        QIAGEN

12.4.1        Key Facts

12.4.2        Business Description

12.4.3        Products and Services

12.4.4        Financial Overview

12.4.5        SWOT Analysis

12.4.6        Key Developments

12.5        Immunarray Pvt. Ltd.

12.5.1        Key Facts

12.5.2        Business Description

12.5.3        Products and Services

12.5.4        Financial Overview

12.5.5        SWOT Analysis

12.5.6        Key Developments

12.6        Quest Diagnostics Incorporated

12.6.1        Key Facts

12.6.2        Business Description

12.6.3        Products and Services

12.6.4        Financial Overview

12.6.5        SWOT Analysis

12.6.6        Key Developments

12.7        Perkin Elmer, Inc.

12.7.1        Key Facts

12.7.2        Business Description

12.7.3        Products and Services

12.7.4        Financial Overview

12.7.5        SWOT Analysis

12.7.6        Key Developments

12.8        MERCK KGaA

12.8.1        Key Facts

12.8.2        Business Description

12.8.3        Products and Services

12.8.4        Financial Overview

12.8.5        SWOT Analysis

12.8.6        Key Developments

13.        Appendix

13.1        Glossary of Terms

LIST OF TABLES

Table 1.              Asia Pacific Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 2.              Asia Pacific Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 3.              Asia Pacific Neurological Biomarker Market, by End-User– Revenue and Forecast to 2027 (USD Million)

Table 4.              China Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 5.              China Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 6.              China Neurological Biomarker Market, by End-User– Revenue and Forecast to 2027 (USD Million)

Table 7.              Japan Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 8.              Japan Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 9.              Japan Neurological Biomarker Market, by End-User– Revenue and Forecast to 2027 (USD Million)

Table 10.            India Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 11.            India Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 12.            India Neurological Biomarker Market, by End User– Revenue and Forecast to 2027 (USD Million)

Table 13.            South Korea Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 14.            South Korea Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 15.            South Korea Neurological Biomarker Market, by End User– Revenue and Forecast to 2027 (USD Million)

Table 16.            Australia Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 17.            Australia Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 18.            Australia Neurological Biomarker Market, by End User– Revenue and Forecast to 2027 (USD Million)

Table 19.            Glossary of Terms, Neurological Biomarker Market

LIST OF FIGURES

Figure 1.            Neurological Biomarker Market Segmentation

Figure 2.            Neurological Biomarker Market – By Country

Figure 3.            Asia Pacific Neurological Biomarker Market Overview

Figure 4.            Genomic Biomarkers Segment Held Largest Share of Neurological Biomarker Market

Figure 5.            Asia Pacific Neurological Biomarker Market- Leading Country Markets (US$ Million)

Figure 6.            Asia Pacific PEST Analysis

Figure 7.            Expert Opinion

Figure 8.            Neurological Biomarker Market Impact Analysis of Driver and Restraint

Figure 9.            Asia Pacific Neurological Biomarker Market – Revenue Forecast and Analysis – 2019- 2027

Figure 10.          Neurological Biomarker Market Share, by Product, 2019 & 2027 (%)

Figure 11.          Proteomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.          Genomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.          Metabolomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.          Imaging Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15.          Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16.          Neurological Biomarker Market Share, by Application, 2019 & 2027 (%)

Figure 17.          Alzheimer’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.          Parkinson’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.          Schizophrenia Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.          Huntington's Disease Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.          Spinal Muscular Atrophy Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.          Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23.          Neurological Biomarker Market Share, by End User, 2019 & 2027 (%)

Figure 24.          Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.          Clinical Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26.          Research Organizations Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 27.          Asia Pacific: Neurological Biomarker Market, by Key Country – Revenue (2019) (USD Million)

Figure 28.          Asia Pacific Neurological Biomarker Market Revenue and Forecast to 2027 (USD Million)

Figure 29.          China: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.          Japan: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

Figure 31.          India: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

Figure 32.          South Korea: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

Figure 33.          Australia: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)

Figure 34.          Impact of COVID-19 Pandemic in Asia Pacific Country Markets